Arbutus Biopharma launches US$230 million modified Dutch auction tender offer at US$5 to US$5.75 a share
ABUS•Tender offer details
Arbutus launched a modified Dutch auction tender offer to repurchase up to USD 230 million of common shares for cancellation.
The offer price range is set at USD 5 to USD 5.75 per share.
The tender opened today and is scheduled to expire Sept. 29, 2026, at 5:00 p.m. New York time, unless extended or terminated.
Funding and expected share reduction
The repurchase will be funded from cash on hand and is not subject to financing or a minimum tender condition.
At full subscription, the buyback would equal 20.2% to 23.2% of shares outstanding as of Aug. 19, 2026.
